Wednesday - May 14, 2025

Graphite One

Medical Cannabis Stocks

Company
Last Trade
Change
Volume
Shares Out
Market Cap
US$ 6.10
0.00 0.00
0
17.33M
US$ 105.710M
US$ 1.30
0.00 0.00
0
53.94M
US$ 70.120M
US$ 0.16
0.00 0.00
0
286.94M
US$ 45.050M
US$ 0.25
0.00 0.00
0
138.96M
US$ 34.740M
US$ 0.71
0.00 0.00
0
44.00M
US$ 31.240M
US$ 0.07
0.0055 8.66
181,777
411.12M
US$ 28.370M
US$ 0.06
0.007 13.46
53,800
447.68M
US$ 26.410M
US$ 0.02
-0.0038 -15.32
7,500
541.70M
US$ 11.380M
US$ 0.06
0.00 0.00
0
169.74M
US$ 10.180M
US$ 0.02
0.00 0.00
0
403.26M
US$ 6.090M
US$ 0.03
0.0005 1.69
1.22M
184.26M
US$ 5.530M
US$ 0.02
0.00 0.00
0
328.70M
US$ 5.030M
US$ 1.60
0.04 2.56
15,827
3.09M
US$ 4.940M
US$ 0.02
0.00 0.00
0
163.94M
US$ 4.020M
US$ 0.03
-0.0049 -14.04
13,500
125.43M
US$ 3.760M
US$ 0.006
-0.0009 -13.04
309,000
490.47M
US$ 2.940M
US$ 1.21
0.01 0.85
81,105
1.43M
US$ 1.730M
US$ 0.004
0.00 0.00
0
308.39M
US$ 1.230M
US$ 0.007
0.00 0.00
0
147.69M
US$ 1.030M
US$ 0.30
-0.27 -47.09
699
3.07M
US$ 921K
US$ 0.0009
0.00 0.00
0
423.36M
US$ 381K
US$ 0.0087
0.00 0.00
0
38.91M
US$ 339K
US$ 0.0001
0.00 0.00
0
175.99M
US$ 18K
US$ 0.00
0.00 0.00
0
102.36M
US$ 102
US$ 0.00
0.00 0.00
0
70.39M
US$ 70
US$ 0.00
0.00 0.00
0
5.84B
US$ -
US$ 0.00
0.00 0.00
0
407.07M
US$ -

Medical Cannabis News


FLUENT: Introducing Entourage: A B2B Wholesale Platform Serving the New York Cannabis Market

    Offering a Curated Portfolio of Brands Including MOODS, MOODS Black, and KNACK NEW YORK, May 12, 2025 (GLOBE NEWSWIRE) --  FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), announces Entourage, a new wholesale cannabis platform serving licensed retailers across New York, officially launching with a curated portfolio of trusted and emerging brands. Developed in... Read more


    TILT Holdings: Curaleaf International, in Partnership with Jupiter Research, Secures EU Medical Device Certification for Europe's First Handheld Liquid Inhalation Device

      LONDON, May 12, 2025 /CNW/ -- Curaleaf International, part of Curaleaf Holdings, Inc. (TSX: CURA) in collaboration with Jupiter Research LLC, a subsidiary of TILT Holdings Inc. ("TILT") (Cboe CA: TILT) (OTCPK: TLLTF), has secured regulatory approval for the first handheld liquid inhalation device designed for precise medical cannabis administration. This EU medical device certification (Regulation... Read more


      Innocan Pharma First Granted Patent in Mexico for its Topical Pain Relief

        Innocan's first fully-granted patent in Mexico Covers Innocan's proprietary cannabis-based pain relief topical Indication of Innocan's growing intellectual property portfolio HERZLIYA, Israel and CALGARY, AB, May 6, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries,... Read more


        Tilray Medical Introduces Cannabis Edibles in Australia

          SYDNEY, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), a global company in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, has announced the availability of its medical cannabis edibles, Good Supply Pastilles, to... Read more


          FLUENT Reports Fourth Quarter and Full Year 2024 Results

            TAMPA, Fla., April 17, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company, today announced its financial and operating results for the fourth quarter and full year ended December 31, 2024. Unless otherwise indicated, all financial results are presented in U.S. dollars. Management Commentary "Closing... Read more


            FLUENT Introduces MOODS Black to Florida Market

              TAMPA, Fla., April 15, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a national cannabis company operating under the FLUENT™ brand, proudly announces the launch of MOODS Black, an extension of its acclaimed MOODS lineup. Featuring cannabis-derived terpenes and high-potency cannabis oil, MOODS Black is crafted to deliver an elevated and authentic... Read more


              Trulieve Cannabis to Open Medical Cannabis Dispensary in St. Petersburg, Florida

                New Pinellas County location will host grand opening celebration Friday, April 11th TALLAHASSEE, Fla., April 9, 2025 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in St. Petersburg, Florida. A grand opening celebration... Read more


                Body and Mind Lynwood IL Dispensary Grand Opening and Corporate Update

                  Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - April 8, 2025) - Body and Mind Inc. (CSE: BAMM) (OTC Pink: BMMJ) (the "Company" or "BaM") is pleased to announce the Grand Opening event at the newly opened Lynwood Illinois dispensary. "We are excited to host the Grand Opening event on April 12th at 12:00 PM at our Lynwood dispensary conveniently, located at the corners of Glenwood... Read more


                  Innocan Pharma Broadens Intellectual Property Coverage for its Liposomal CBD Injection Across Asia and Announces Private Placement of Units

                    Innovative Chronic Pain Treatment expand IP Protection in China's US$163 Billion Pharmaceutical Market HERZLIYA, Israel and CALGARY, AB, April 7, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that a divisional application for its Chinese (CN) li... Read more


                    FLUENT Expands Hyer Kind Brand to the New York Market

                      NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), a national cannabis company operating under the FLUENT™ brand, is proud to announce the launch of Hyer Kind, a cosmic voyage into the world of premium cannabis, in the state of New York. Hyer Kind’s expertly crafted live rosin-infused pre-rolls “Boosters” are now available... Read more


                      Canopy Growth and Spectrum Therapeutics Announce Spectrum Reserve, A New Premium Medical Cannabis Brand

                        New Brand Features Premium Genetics, Selected for Potency, Terpenes, and Consistency SMITHS FALLS, Ontario / Apr 02, 2025 / Business Wire / Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to improve lives, has launched Spectrum Reserve, a new premium medical cannabis brand... Read more


                        1933 Industries Reports Second Quarter 2025 Financial Results

                          VANCOUVER, BC / ACCESS Newswire / March 31, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its second quarter financial results ("Q2 2025") for the three and six months ended January 31, 2025 and 2024 ("Fiscal 2025"). All amounts expressed are in Canadian dollars. The Company owns... Read more


                          MediPharm Labs Reports Full Year & Fourth Quarter 2024 Results

                            Annual Net Revenue Increase of 27% to $42M, Driven by Record $18M International Medical Cannabis Revenue and Approaching Positive Adjusted EBITDA(1) for Q4. TORONTO, March 31, 2025 /CNW/ - MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) ("MediPharm", "MediPharm Labs" or the "Company") a pharmaceutical company specialized in precision-based cannabinoids, today announced its financial... Read more


                            Innocan Pharma Reports Full Year 2024 Results with Revenues more than Doubling to US $29.4 million

                              HERZLIYA, Israel and CALGARY, AB, March 31, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on developing innovative drug delivery platform technologies is pleased to announce its audited financial consolidated results for the year ended December 31, 2024. Full Year 2024 Financial Highlights... Read more


                              CV Sciences Reports Fiscal Year-End 2024 Financial Results

                                SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the year and quarter ended December 31, 2024. Fiscal 2024, Fourth Quarter 2024 and Recent... Read more


                                Trulieve Cannabis to Open Medical Cannabis Dispensary in North Miami Beach, Florida

                                  New Miami-Dade County location will host grand opening celebration Friday, March 21st TALLAHASSEE, Fla., March 18, 2025 /CNW/ -- Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) ("Trulieve" or "the Company"), a leading and top-performing cannabis company in the U.S., today announced the opening of a new medical cannabis dispensary in North Miami Beach, Florida. A grand opening... Read more


                                  Tilray Medical Launches Tilray Craft: Introducing High THC, High Terpene Genetics to the German Medical Cannabis Market

                                    NEUMÜNSTER, Germany, March 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare, is pleased to announce the introduction of Tilray... Read more


                                    Cresco Labs to Operate Kentucky’s Largest Medical Cannabis Cultivation License

                                      CHICAGO / Mar 10, 2025 / Business Wire / Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) (FSE: 6CQ) (“Cresco Labs” or the “Company”), the industry leader in branded cannabis products with a portfolio of America’s most popular brands and the operator of Sunnyside dispensaries, today announced its management services agreement with a Tier 3 Cultivation License in Kentucky (the “Cultivation License”).... Read more


                                      PharmaCielo Reports Q4 2024 Financial Results

                                        PharmaCielo achieved 143% Year-Over-Year Sales Growth, Generating Year-to-Date Q4 Total Revenue of $3.54 Million. Revenues and Gross Profit Margin Increased with More Diverse Customer Base. Q4 Cash Flow Continued to Improve and Adjusted EBITDA Increased by $1.1 Million versus Last Year Reflecting Strong Sales Growth and Reduced Costs. Financial Year-End is March 31. Audited Financial Statements... Read more


                                        Canopy Growth Announces Entry of Tweed Brand to German Medical Cannabis Market

                                          Four new Tweed strains available through an agreement with Portugal-based Gro-Vida Tweed Glitter Bomb strain launched in December 2024 through an agreement with German-based Cansativa SMITHS FALLS, ON, Feb. 27, 2025 /CNW/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis to... Read more


                                          Village Farms Expands Medical Cannabis Distribution to New Zealand

                                            VANCOUVER, British Columbia, Feb. 27, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) today announced its first shipment to New Zealand through its wholly-owned subsidiary Pure Sunfarms. The shipment features Pink Kush, the top-selling dried flower strain over the past four years1 in Canada, the largest federally legal market in... Read more


                                            Florida's Premier Medical Marijuana Provider FLUENT™ Relocates North Miami Beach location to Aventura

                                              Offering a new, expanded and improved retail experience for Miami residents.  TAMPA, Fla., Feb. 27, 2025 /CNW/ - FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a vertically-integrated, multi-state cannabis company operating under the FLUENT™ brand, today announced the relocation of its Miami dispensary from North Miami Beach to Aventura. Patients with a valid... Read more


                                              1933 Industries Announces First Quarter 2025 Financial Report

                                                VANCOUVER, BC / ACCESS Newswire / February 27, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its first quarter financial results ("Q1 2025") for the three months ended October 31, 2024 and 2023. All amounts expressed are in Canadian dollars. The Company owns 91% of Alternative... Read more


                                                1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 Million

                                                  VANCOUVER, BC / ACCESS Newswire / February 25, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF) (OTC PINK:TGIFF), a Nevada-focused cannabis cultivator and producer, is pleased to announce its fourth quarter ("Q4 2024") and audited annual financial results for the years ended July 31, 2024 and 2023 ("Fiscal 2024"). All amounts expressed are in Canadian dollars. The Company... Read more


                                                  Charlotte's Web Holdings: DeFloria Receives Investigational New Drug Application Clearance from FDA for Phase 2 Clinical Trial of AJA001, an Oral Cannabinoid Drug Being Developed for the Treatment of Autism...

                                                    DeFloria plans to initiate a Phase 2 clinical trial by mid-year 2025 LITTLETON, Colo., Feb. 24, 2025 /PRNewswire/ -- DeFloria, Inc., a collaboration between Ajna BioSciences PBC and Charlotte's Web Holdings, Inc. (TSX: CWEB, OTCQX: CWBHF), announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Investigational New Drug (IND) application for AJA001, an orally delivered,... Read more


                                                    Aurora Cannabis Expands Medical Cannabis Pastille Offerings in Australia

                                                      Canada's Leading Medical Cannabis Company Broadens Innovative Product Portfolio to Growing Market in Australia EDMONTON, AB, Feb. 20, 2025 /CNW/ - Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, has announced today the company's extended pastille offerings in Australia. This expansion marks another meaningful step in Aurora's deep commitment... Read more


                                                      Breaking Down Barriers: Aurora Cannabis Eases Patient Access to High Quality Medical Cannabis Products in Australia

                                                        Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession Card Requirements to Access IndiMed Products in Australia EDMONTON, AB, Feb. 14, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently... Read more


                                                        Tilray Expands Medical Cannabis Portfolio in Germany

                                                          NEUMÜNSTER, Germany, Feb. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Medical (“Tilray”), a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), and a global leader in medical cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, is pleased to announce the expansion of its industry-leading medical cannabis... Read more


                                                          Innocan Pharma's Liposomal CBD Injection Shows Breakthrough Pain Relief in Elderly Donkey with Osteoarthritis

                                                            This is the second successful treatment in a donkey, demonstrating the potential of Innocan's Liposomal CBD injection for human and veterinary use HERZLIYA, Israel and CALGARY, AB, Feb. 10, 2025 /CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce the successful... Read more


                                                            Body and Mind Announces Sale of Illinois Assets and Provides Corporate Update

                                                              Las Vegas, Nevada and Vancouver, British Columbia--(Newsfile Corp. - January 30, 2025) - Body and Mind Inc. (CSE: BAMM) (OTC Pink: BMMJ) (the "Company" or "BaM") is pleased to announce that it has entered into definitive agreements for the sale of its Illinois assets, NMG IL 1, LLC ("NMG IL 1") and NMG IL 4, LLC ("NMG IL 4") to Rubino Ventures IL, LLC d/b/a/ Dutchess Cannabis, an Illinois cannabis... Read more

                                                              COPYRIGHT ©2025 GREEN STOCK NEWS